Julian R. De Ruiter
Amsterdam, NH 1066CX, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors.
Journal: Cell reports
Published: September 06, 2022
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: September 01, 2022
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Journal: Nature communications
Published: April 14, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: January 19, 2021
Mouse models in the era of large human tumour sequencing studies.
Journal: Open biology
Published: May 03, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data.
Journal: BMC bioinformatics
Published: February 16, 2018
Last Updated: 09/26/2026